Remerispharma

India
Develops, markets, and supplies pharmaceutical products for health needs worldwide.

About Remerispharma

Remerispharma is a Healthcare company based in India. Develops, markets, and supplies pharmaceutical products for health needs worldwide. It operates on a B2B model. Its Indian entity Remeris Pharma Private Limited reported revenue of β‚Ή27.9 Lakh. Remerispharma offers products and services including Tablets, Capsules, Ointment, and Liquid. Its focus areas include Pharmaceuticals, General Medicines, Drug Delivery Systems and Therapeutic Products.

Company details

Remeris Pharma is a technology-driven company located in Vadodara, Gujarat, India, specializing in the development and marketing of pharmaceutical products such as tablets, capsules, ointments, and liquids. It offers general medicines across categories like antibiotics and cardiac drugs, focusing on high-quality, affordable solutions for domestic and global markets. The company emphasizes innovation in drug delivery systems and serves clients through distribution networks.

  • Headquarters India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website remerispharma.com
  • Legal Name Remeris Pharma Private Limited
  • Date of Incorporation 24 Jan, 2020
  • Jurisdiction Vadodara, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹27.9 Lakh

    FY 2024 · -2% YoY

  • Net Profit
    ₹1.7 Lakh

    FY 2024 · 6% margin

  • EBITDA
    ₹1.8 Lakh

    FY 2024 · 7% margin

Products & Services of Remerispharma

Remerispharma offers a comprehensive portfolio of products and services, including Tablets, Capsules, Ointment, and Liquid.

Tablets
Solid Dosage Form

Solid unit dosage form with active substances and excipients

Capsules
Dosage Form

Solid preparations containing pharmaceutical ingredients

Ointment
Topical Preparation

Semisolid formulations for external application

Liquid
Liquid Dosage Form

Solutions and syrups for easy administration

Board of directors of Remeris Pharma Private Limited (Remerispharma)

Remeris Pharma Private Limited is the primary company behind Remerispharma. The board of Remeris Pharma Private Limited currently have 4 directors; the longest-serving is Piyush Chaturbhai Patel, appointed in 2020. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Piyush Chaturbhai Patel
DIN 07837624
Director24 Jan 20206 yrs 9 moRemeris Pharma Private Limited
Dhavalkumar Chhotalal Barot
DIN 09375949
Director25 Oct 20215 yrsRemeris Pharma Private Limited
Bharat Harivallavdas Shah
DIN 02194299
Director28 Jan 20224 yrs 9 moRemeris Pharma Private Limited
Dhaval Rajnikant Zaveri
DIN 09513061
Director28 Jan 20224 yrs 9 moRemeris Pharma Private Limited

Financials of Remerispharma

Figures of Remeris Pharma Private Limited, the primary company behind Remerispharma, for FY 2024. Revenue was ₹27.9 Lakh (-2% year on year). Net profit was ₹1.7 Lakh (6% margin). EBITDA was ₹1.8 Lakh (7% margin). Revenue has grown at a compounded annual rate of -19% over three years.

  • ₹27.9 LakhRevenue · FY 2024 · -2% YoY
  • ₹1.7 LakhNet profit · 6% margin
  • ₹1.8 LakhEBITDA · 7% margin
  • ₹1 LakhPaid-up capital
  • -19%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Remeris Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Remerispharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmacy & Healthcare Retail Systems

2 companies that operate in the same segment as Remerispharma (Pharmacy & Healthcare Retail Systems) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Offers a B2B managed marketplace for pharmacies
2019Bengaluru, Karnataka, IndiaUSD 20.02 MUSD 20.23 M218
Digital healthcare tools are offered for pharmacies and clinics management.
2012Mumbai, Maharashtra, IndiaUSD 1.19 BUSD 719.01 M215
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Remerispharma

Remerispharma is headquartered in India.

The primary company behind Remerispharma, Remeris Pharma Private Limited, reported revenue of β‚Ή27.9 Lakh for FY 2024, down 2% year on year.

Remeris Pharma is a technology-driven company located in Vadodara, Gujarat, India, specializing in the development and marketing of pharmaceutical products such as tablets, capsules, ointments, and liquids. It offers general medicines across categories like antibiotics and cardiac drugs, focusing on high-quality, affordable solutions for domestic and global markets. The company emphasizes innovation in drug delivery systems and serves clients through distribution networks.

Remerispharma offers Tablets, Capsules, Ointment, and Liquid.

Remerispharma operates through Remeris Pharma Private Limited.

The legal entities of Remerispharma currently have 4 directors, including Bharat Harivallavdas Shah, Dhaval Rajnikant Zaveri, Piyush Chaturbhai Patel and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available